Zynerba Pharmaceuticals - Hot or Not 2

Zynerba Pharmaceuticals – Hot or Not

Zynerba Pharmaceuticals (Nasdaq:ZYNE) is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments. It has a market cap of $83.3 million, and is not profitable.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether Zynerba Pharmaceuticals is hot or not.


Leave a Comment

Your email address will not be published. Required fields are marked *

error: Content is protected !!


Click one of our representatives below to chat on WhatsApp or send us an email to [email protected]


× Order Via Whatsapp?